|
"pei jer chen"的相关文件
显示项目 731-740 / 883 (共89页)
<< < 69 70 71 72 73 74 75 76 77 78 > >>
每页显示[10|25|50]项目
| 臺大學術典藏 |
2018-09-10T09:47:27Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Chen, Hung-Chia;Liu, Chen-Hua;Jeng, Jenher;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; Hsu, Ching-Sheng; Hsu, Ching-Sheng; PEI-JER CHEN; Hsu, Shih-Jer; Hsu, Shih-Jer; CHEN-HUA LIU; Chen, Hung-Chia; Chen, Hung-Chia; Liu, Chen-Hua; DING-SHINN CHEN; Liu, Chen-Hua; Jeng, Jenher; JIA-HORNG KAO; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:26Z |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, Hung-Chih;Chen, Chi-Ling;Shen, Yueh-Chi;Peng, Cheng-Yuan;Liu, Chun-Jen;Tseng, Tai-Chung;Su, Tung-Hung;Chuang, Wan-Long;Yu, Ming-Lung;Dai, Chia-Yen;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Yang, H.-C. and Chen, C.-L. and Shen, Y.-C. and Peng, C.-Y. and Liu, C.-J. and Tseng, T.-C. and Su, T.-H. and Chuang, W.-L. and Yu, M.-L. and Dai, C.-Y. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Yang, Hung-Chih; HUNG-CHIH YANG; CHUN-JEN LIU; Chen, Chi-Ling; Shen, Yueh-Chi; PEI-JER CHEN; Peng, Cheng-Yuan; CHEN-HUA LIU; TUNG-HUNG SU; Liu, Chun-Jen; Liu, Chun-Jen; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:25Z |
Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients
|
Yuan, Quan;Song, Liu-Wei;Liu, Chun-Jen;Li, Zhuo;Liu, Ping-Guo;Huang, Cheng-Hao;Yan, Yan;Ge, Sheng-Xiang;Wang, Ying-Bin;Peng, Cheng-Yuan;Zhang, Jun;Kao, Jia-Horng;Chen, Ding-Shinn;Chen, Pei-Jer;Xia, Ning-Shao; CHUN-JEN LIU; Yuan, Quan; Song, Liu-Wei; PEI-JER CHEN; DING-SHINN CHEN; Liu, Chun-Jen; JIA-HORNG KAO; Li, Zhuo; Liu, Ping-Guo; Huang, Cheng-Hao; Yan, Yan; Ge, Sheng-Xiang; Wang, Ying-Bin; Peng, Cheng-Yuan; Zhang, Jun; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Pei-Jer; Xia, Ning-Shao |
| 臺大學術典藏 |
2018-09-10T09:47:24Z |
Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C
|
Su, Tung-Hung;Liu, Chen-Hua;Liu, Chun-Jen;Chen, Chi-Ling;Ting, Te-Tien;Tseng, Tai-Chung;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; Su, Tung-Hung;Liu, Chen-Hua;Liu, Chun-Jen;Chen, Chi-Ling;Ting, Te-Tien;Tseng, Tai-Chung;Chen, Pei-Jer;Kao, Jia-Horng;Chen, Ding-Shinn; Su, T.-H. and Liu, C.-H. and Liu, C.-J. and Chen, C.-L. and Ting, T.-T. and Tseng, T.-C. and Chen, P.-J. and Kao, J.-H. and Chen, D.-S.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; Su, Tung-Hung; Su, Tung-Hung; CHUN-JEN LIU; Liu, Chen-Hua; Liu, Chen-Hua; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Chi-Ling; TUNG-HUNG SU; Ting, Te-Tien; DING-SHINN CHEN; JIA-HORNG KAO; Tseng, Tai-Chung; Chen, Pei-Jer; Chen, Pei-Jer; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Ding-Shinn; 陳祈玲 |
| 臺大學術典藏 |
2018-09-10T09:42:02Z |
ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers
|
Liu, Wan-Hsin; Chen, Chao-Hung; Yeh, Kun-Huei; Li, Chiao-Ling; Wu, Yi-Jinn; Chen, Ding-Shinn; Chen, Pei-Jer; Yeh, Shiou-Hwei; Jin, Dong-Yan; Liu, W.-H. and Chen, C.-H. and Yeh, K.-H. and Li, C.-L. and Wu, Y.-J. and Chen, D.-S. and Chen, P.-J. and Yeh, S.-H.; PEI-JER CHEN; Liu, Wan-Hsin; Chen, Chao-Hung; KUN-HUEI YEH; DING-SHINN CHEN; Yeh, Kun-Huei; SHIOU-HWEI YEH; Li, Chiao-Ling; Wu, Yi-Jinn; Chen, Ding-Shinn; Chen, Pei-Jer; Yeh, Shiou-Hwei; Jin, Dong-Yan |
| 臺大學術典藏 |
2018-09-10T09:42:01Z |
Telomerase-specific oncolytic adenoviral therapy for orthotopic hepatocellular carcinoma in HBx transgenic mice
|
Lin, Wei-Hsiang;Yeh, Shiou-Hwei;Yang, Wan-Jen;Yeh, Kun-Huei;Fujiwara, Toshiyoshi;Nii, Aisuke;Chang, Stanley Shi-Chung;Chen, Pei-Jer; Lin, W.-H. and Yeh, S.-H. and Yang, W.-J. and Yeh, K.-H. and Fujiwara, T. and Nii, A. and Chang, S.S.-C. and Chen, P.-J.; 葉坤輝 ;葉秀慧 ;陳培哲; 葉坤輝 ;葉秀慧 ;陳培哲; Lin, Wei-Hsiang; PEI-JER CHEN; Yeh, Shiou-Hwei; Yeh, Shiou-Hwei; KUN-HUEI YEH; Yeh, Shiou-Hwei; SHIOU-HWEI YEH; Yang, Wan-Jen; Yeh, Kun-Huei; Yeh, Kun-Huei; Fujiwara, Toshiyoshi; Nii, Aisuke; Chang, Stanley Shi-Chung; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Pei-Jer |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up.
|
Yu, Ming-Lung; HUNG-CHIH YANG; CHUN-JEN LIU; Lee, Chuan-Mo; Lee, Chuan-Mo; PEI-JER CHEN; Chen, Chi-Ling; Chen, Chi-Ling; CHEN-HUA LIU; Chuang, Wan-Long; Lu, Sheng-Nan; Lu, Sheng-Nan; DING-SHINN CHEN; Liu, Chen-Hua; JIA-HORNG KAO; Liu, Chen-Hua; Wu, Shun-Sheng; Wu, Shun-Sheng; Liao, Li-Ying; Kuo, Hsing-Tao; Kuo, Hsing-Tao; Chao, You-Chen; Tung, Shui-Yi; Tung, Shui-Yi; Yang, Sien-Sing; Kao, Jia-Horng; Kao, Jia-Horng; Su, Wei-Wen; Su, Wei-Wen; Lin, Chih-Lin; Lin, Chih-Lin; Yang, Hung-Chih; Yang, Hung-Chih; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Liu, Chun-Jen; Liu, Chun-Jen; Yu, Ming-Lung;Lee, Chuan-Mo;Chen, Chi-Ling;Chuang, Wan-Long;Lu, Sheng-Nan;Liu, Chen-Hua;Wu, Shun-Sheng;Liao, Li-Ying;Kuo, Hsing-Tao;Chao, You-Chen;Tung, Shui-Yi;Yang, Sien-Sing;Kao, Jia-Horng;Su, Wei-Wen;Lin, Chih-Lin;Yang, Hung-Chih;Chen, Pei-Jer;Chen, Ding-Shinn;Liu, Chun-Jen |
| 臺大學術典藏 |
2018-09-10T09:39:55Z |
Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads.
|
Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Chen, Chi-Ling;Hsu, Cheng-An;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳祈玲; CHUN-JEN LIU; Tseng, Tai-Chung; Tseng, Tai-Chung; Liu, Chun-Jen; PEI-JER CHEN; Yang, Hung-Chih; CHEN-HUA LIU; TUNG-HUNG SU; Su, Tung-Hung; DING-SHINN CHEN; Wang, Chia-Chi; Wang, Chia-Chi; Chen, Chi-Ling; Hsu, Cheng-An; Hsu, Cheng-An; Kuo, Stephanie Fang-Tzu; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen, K.-F.;Chen, H.-L.;Shiau, C.-W.;Liu, C.-Y.;Chu, P.-Y.;Tai, W.-T.;Ichikawa, K.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:26:15Z |
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
|
MING-WHEI YU; Shih, Wei-Liang; Chang, Hung-Chuen; CHUN-JEN LIU; Liaw, Yun-Fan; Liaw, Yun-Fan; PEI-JER CHEN; Lin, Shi-Ming; Lin, Shi-Ming; WEI-LIANG SHIH; Lee, Shou-Dong; Lee, Shou-Dong; Chen, Pei-Jer; Chen, Pei-Jer; Liu, Chun-Jen; Liu, Chun-Jen; Lin, Chih-Lin; Lin, Chih-Lin; Yu, Ming-Whei; Shih, Wei-Liang;Chang, Hung-Chuen;Liaw, Yun-Fan;Lin, Shi-Ming;Lee, Shou-Dong;Chen, Pei-Jer;Liu, Chun-Jen;Lin, Chih-Lin;Yu, Ming-Whei |
显示项目 731-740 / 883 (共89页)
<< < 69 70 71 72 73 74 75 76 77 78 > >>
每页显示[10|25|50]项目
|
